RecallDepth
Class III Terminated

Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04

Company
Teva Pharmaceuticals Usa
Recall Initiated
October 28, 2021
Posted
November 24, 2021
Recall Number
D-0235-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
64,978 patches
Firm Location
Parsippany, NJ, United States

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot# 1369117B, exp. date 11/2021

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class III Drug recalls